Insider · CIK 0002139522
William Drake Richey
Files at TPST (Tempest Therapeutics, Inc.). First filing -, latest -.
In brief
William Drake Richey files SEC Form 4 as director at TPST (Tempest Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; William Drake Richey has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | TPST Tempest Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jun 8, 2026 |
Questions about William Drake Richey
Answered from the filings on this page, as of the latest one.
Is William Drake Richey buying or selling?
William Drake Richey has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did William Drake Richey's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and William Drake Richey has 0.
Where does William Drake Richey file Form 4?
William Drake Richey has filed Form 4 at TPST (Tempest Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.